<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02608164</url>
  </required_header>
  <id_info>
    <org_study_id>REC/15/0083</org_study_id>
    <nct_id>NCT02608164</nct_id>
  </id_info>
  <brief_title>A Comparison of Capsules and Oral Spray Solution as Methods of Delivering Vitamin D3 and Raising Status</brief_title>
  <acronym>SCD3</acronym>
  <official_title>A Comparison of Capsules and Oral Spray Solution as Methods of Delivering Vitamin D3 and Raising Status: a Randomised Crossover Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ulster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northern Ireland Executive</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>HSC Public Health Agency</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Ulster</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the effectiveness of a vitamin D3 oral spray solution with
      capsules at raising vitamin D status over winter.

      This randomised crossover trial will aim to recruit a total of 22 healthy participants for a
      total of two 4-week interventions separated by a 10-week washout.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total 25-hydroxyvitamin D concentration</measure>
    <time_frame>At baseline and weeks 4, 14 and 18</time_frame>
    <description>Total 25-hydroxyvitamin D concentration will be determined using liquid chromatography-tandem mass spectrometry in collected serum samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biomarkers of vitamin D metabolism</measure>
    <time_frame>At baseline and weeks 4, 14 and 18</time_frame>
    <description>Biomarkers of vitamin D metabolism, including parathyroid hormone and adjusted calcium will be quantified in collected serum samples by ELISA and using a clinical chemistry analyser</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary vitamin D intake</measure>
    <time_frame>At week 18 only</time_frame>
    <description>Dietary vitamin D and calcium intake will be estimated using a validated food frequency questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Vitamin D Concentration</condition>
  <condition>Vitamin D Status</condition>
  <arm_group>
    <arm_group_label>Vitamin D oral spray solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>An oral spray solution containing 3000IU (75micrograms) vitamin D3 per spray</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D capsules</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A capsule containing 3000IU (75micrograms) vitamin D3 per capsule</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>3000IU(75Î¼g) vitamin D3</intervention_name>
    <arm_group_label>Vitamin D oral spray solution</arm_group_label>
    <arm_group_label>Vitamin D capsules</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Apparently healthy

          -  Over the age of 18

        Exclusion Criteria:

          -  Those that intend to consume a supplement containing vitamin D at any point during the
             study

          -  Those under the age of 18.

          -  Individuals that are on prescribed medication that is known to affect vitamin D
             metabolism

          -  Those following a vegan diet

          -  Sun-bed users

          -  Participants that are planning a sun holiday during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pamela J Magee, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Ulster</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Human Intervention Studies Unit (HISU), University of Ulster</name>
      <address>
        <city>Coleraine</city>
        <state>Londonderry</state>
        <zip>BT52 1SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2015</study_first_submitted>
  <study_first_submitted_qc>November 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2015</study_first_posted>
  <last_update_submitted>May 24, 2016</last_update_submitted>
  <last_update_submitted_qc>May 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ulster</investigator_affiliation>
    <investigator_full_name>Dr Pamela Magee</investigator_full_name>
    <investigator_title>Dr Pamela Magee</investigator_title>
  </responsible_party>
  <keyword>Healthy adults</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

